| RS1395524891 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS1395525519 |
PEX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS139552714 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Naxos disease, Arrhythmogenic right ventricular dysplasia 12 |
| RS1395527274 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteopetrosis, Autosomal recessive osteopetrosis 4 |
| RS139552940 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, Bethlem myopathy 1A |
| RS139552984 |
ROBO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Vesicoureteral reflux 2, Vesicoureteral reflux 2 |
| RS139553131 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS139553755 |
ADAMTS18
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139555085 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1395551564 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Inborn genetic diseases |
| RS1395554751 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS139555567 |
LONP1
|
Health Risk |
Conflicting classifications of pathogenicity |
LONP1-related disorder, LONP1-related disorder |
| RS1395558232 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1395561739 |
EXOSC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontoneocerebellar hypoplasia, Pontocerebellar hypoplasia type 1B |
| RS139557480 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer, RNF43-related disorder |
| RS1395575712 |
DNMT3A
|
Health Risk |
Pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS139557851 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS139558261 |
NYX
|
Health Risk |
Conflicting classifications of pathogenicity |
NYX-related disorder, NYX-related disorder |
| RS139558481 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiomyopathy |
| RS139558513 |
STIM1
|
Health Risk |
Conflicting classifications of pathogenicity |
STIM1-related disorder, Myopathy |
| RS1395588065 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1395589626 |
ADGRL1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Global developmental delay |
| RS139559367 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1R, Hypertrophic cardiomyopathy 11 |
| RS139559495 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 12, Naxos disease |
| RS1395597191 |
FUCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fucosidosis, Fucosidosis |
| RS1395597644 |
COL6A3
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Bethlem myopathy 1A |
| RS139559830 |
COL17A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS139559937 |
VCL
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1W, Cardiovascular phenotype |
| RS139560004 |
CCDC39
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 14 |
| RS139560074 |
IFT172
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS1395608434 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 25, Retinitis pigmentosa |
| RS139561812 |
PGAM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type X, Glycogen storage disease type X |
| RS1395620536 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS139562274 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1395631005 |
CAMTA1
|
Health Risk |
Pathogenic |
— |
| RS139563689 |
TMPRSS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcytic anemia, Microcytic anemia |
| RS139564196 |
CLCNKA
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 4B, Bartter disease type 4B |
| RS1395644015 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS139564795 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS1395648272 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Actin accumulation myopathy, Congenital myopathy 2b |
| RS1395648308 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS139564938 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Autoinflammatory syndrome |
| RS1395650269 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS139565972 |
FGF8
|
Health Risk |
Likely pathogenic |
Holoprosencephaly sequence, Holoprosencephaly sequence |
| RS139566676 |
DNAAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS139568056 |
GDF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS139568495 |
LAMB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139569694 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS1395700335 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS139570101 |
TEKT3
|
Health Risk |
Pathogenic |
Spermatogenic failure 81, Spermatogenic failure 81 |
| RS139570786 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS139570869 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS139571947 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS139571975 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blau syndrome, Inflammatory bowel disease 1 |
| RS139572764 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS139573207 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Budd-Chiari syndrome, Factor V deficiency |
| RS139573311 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS1395737285 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS139574075 |
COLQ
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome |
| RS1395754016 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS139576148 |
IL10RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory bowel disease 28, IL10RA-related disorder |
| RS1395763356 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1395765132 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS1395766003 |
IFT81
|
Health Risk |
Pathogenic |
— |
| RS139576982 |
PNPLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutral lipid storage myopathy, Neutral lipid storage myopathy |
| RS1395775047 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS139579036 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS139579057 |
PLA2G6
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile neuroaxonal dystrophy, Autosomal recessive Parkinson disease 14 |
| RS139579665 |
ANLN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139579796 |
VARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139579816 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiomyopathy |
| RS139580010 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2C, Inborn genetic diseases |
| RS139580489 |
NEFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139580620 |
TNC
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139580877 |
SPEF2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139581346 |
NEBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS139581412 |
CHD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, CHD5-related disorder |
| RS139581644 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS139582106 |
AMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscle AMP deaminase deficiency, Muscle AMP deaminase deficiency |
| RS139582148 |
HSD17B3
|
Health Risk |
Conflicting classifications of pathogenicity |
Testosterone 17-beta-dehydrogenase deficiency, HSD17B3-related disorder |
| RS139582437 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, FLNB-Related Spectrum Disorders |
| RS139583037 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial dysautonomia, Familial dysautonomia |
| RS1395832064 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Tip-toe gait, Inborn genetic diseases |
| RS139583787 |
UCHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Parkinson disease 5, autosomal dominant |
| RS139584756 |
STEAP3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139585796 |
KCTD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy type 3, Inborn genetic diseases |
| RS139585872 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Wolman disease |
| RS139586720 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Congenital muscular dystrophy due to partial LAMA2 deficiency |
| RS139588377 |
KLHL40
|
Health Risk |
Pathogenic |
Nemaline myopathy 8, Nemaline myopathy 8 |
| RS1395885868 |
MUSK
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 9, Fetal akinesia deformation sequence 1 |
| RS139589527 |
MATR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 21, Amyotrophic lateral sclerosis type 21 |
| RS139590550 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS139590686 |
POLG
|
Health Risk |
Likely pathogenic |
POLG-related disorder, Progressive sclerosing poliodystrophy |
| RS139591065 |
BMPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary hypertension, primary |
| RS139591082 |
KCNJ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 2, Bartter disease type 2 |
| RS139591190 |
DBH
|
Health Risk |
Conflicting classifications of pathogenicity |
Orthostatic hypotension 1, Orthostatic hypotension 1 |
| RS139591272 |
LCT
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lactase deficiency, Congenital lactase deficiency |
| RS1395913655 |
CYP17A1
|
Health Risk |
Pathogenic |
17-alpha-hydroxylase/17, 20-lyase deficiency |
| RS1395918076 |
KDM4B
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndromic global developmental delay, Intellectual developmental disorder |
| RS139591993 |
POLK
|
Health Risk |
Pathogenic |
Prostate cancer, Prostate cancer |